- Home
- JWEL vs RDHL Comparison
JWEL vs RDHL Comparison
Compare JWEL & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWEL
- RDHL
- Stock Information
- Founded
- JWEL 2012
- RDHL 2009
- Country
- JWEL China
- RDHL Israel
- Employees
- JWEL N/A
- RDHL 35
- Industry
- JWEL Other Consumer Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- JWEL Consumer Discretionary
- RDHL Health Care
- Exchange
- JWEL Nasdaq
- RDHL Nasdaq
- Market Cap
- JWEL 4.1M
- RDHL 4.3M
- IPO Year
- JWEL 2021
- RDHL N/A
- Fundamental
- Price
- JWEL N/A
- RDHL $2.02
- Analyst Decision
- JWEL
- RDHL
- Analyst Count
- JWEL 0
- RDHL 0
- Target Price
- JWEL N/A
- RDHL N/A
- AVG Volume (30 Days)
- JWEL 10.7K
- RDHL 19.3K
- Earning Date
- JWEL 07-15-2025
- RDHL 08-28-2025
- Dividend Yield
- JWEL N/A
- RDHL N/A
- EPS Growth
- JWEL N/A
- RDHL N/A
- EPS
- JWEL N/A
- RDHL N/A
- Revenue
- JWEL $132,981,531.00
- RDHL $8,042,999.00
- Revenue This Year
- JWEL N/A
- RDHL $381.91
- Revenue Next Year
- JWEL N/A
- RDHL N/A
- P/E Ratio
- JWEL N/A
- RDHL N/A
- Revenue Growth
- JWEL N/A
- RDHL 23.17
- 52 Week Low
- JWEL $1.18
- RDHL $1.71
- 52 Week High
- JWEL $3.71
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- JWEL 80.59
- RDHL 57.04
- Support Level
- JWEL $1.82
- RDHL $1.75
- Resistance Level
- JWEL $2.98
- RDHL $2.08
- Average True Range (ATR)
- JWEL 0.21
- RDHL 0.10
- MACD
- JWEL 0.09
- RDHL 0.03
- Stochastic Oscillator
- JWEL 76.86
- RDHL 85.16
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.